SLX1B-SULT1A4

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, SLX1B-SULT1A4 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated SLX1B-SULT1A4 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher SLX1B-SULT1A4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SLX1B-SULT1A4 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LUAD show a favorable association.

KIRC, COAD, and DLBC are the cancer types where SLX1B-SULT1A4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRCDFSTertileAll0.5250.673<.00165view →
COADDFSTertileAll0.3360.552<.00163view →
DLBCDFSTertileAll0.1130.837<.00150view →
BRCADFSQuartileAll0.4150.551.00642view →
UCECDFSTertileAll0.8260.907.00542view →
BLCADFSMedianII,III,IV0.6980.568.00336view →
KIRPOSQuartileII,III,IV0.1110.794<.00130view →
LIHCOSTertileAll0.3560.540.01421view →
ACCDFSTertileAll0.3900.652.04220view →
PRADDFSTertileAll0.8340.903.02018view →
LUADOSTertileIII,IV0.8030.581.00616view →
READOSQuartileII,III,IV0.8610.314.01416view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

SLX1B-SULT1A4–KIRC (DFS)

Kaplan–Meier survival curve for SLX1B-SULT1A4 RNA-high vs -low samples in KIRC.

Open the KIRC breakdown →

Exploration